We are live on
!
Find out more
DCMM
DG Capital Management (Massachusetts) Portfolio holdings
AUM
$102M
1-Year Est. Return
29.14%
This Fund
S&P 500
This Quarter
Est. Return
+4.98%
1 Year Est. Return
+29.14%
3 Year Est. Return
+96.74%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$165M
AUM Growth
–
Cap. Flow
+$165M
Cap. Flow
% of AUM
99.97%
Top 10 Holdings %
Top 10 Hldgs %
27.59%
Holding
56
New
56
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$6.36M |
| 2 |
Gilead Sciences
GILD
|
+$5.44M |
| 3 |
Citigroup
C
|
+$4.4M |
| 4 |
AbbVie
ABBV
|
+$4.24M |
| 5 |
Chubb
CB
|
+$4.18M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.87% |
| 2 | Financials | 20.48% |
| 3 | Communication Services | 9.49% |
| 4 | Consumer Discretionary | 9.28% |
| 5 | Industrials | 8.78% |
Similar funds
LOT
BGA
PCM
EDRAML
EC
SAMNY
BCCM
EIAM
DG Capital Management (Massachusetts)'s Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for DG Capital Management (Massachusetts), which disclosed 56 positions worth $165M. Its ten largest holdings account for 28% of the portfolio.
Its largest position is Biogen: 29,755 shares worth $6.4M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, followed by Financials and Communication Services.
- DG Capital Management (Massachusetts)'s largest Q2 2013 buy was Biogen: 29,755 shares worth $6.4M.
- DG Capital Management (Massachusetts)'s ten largest holdings make up 28% of its $165M portfolio in Q2 2013.
- DG Capital Management (Massachusetts) disclosed 56 positions in Q2 2013, its first 13F filing on record.
Based on DG Capital Management (Massachusetts)'s 13F filing for Q2 2013, filed 5 Aug 2013.